Utah Medical Products, Inc. (UTMD)
58.11
+0.41
(+0.71%)
USD |
NASDAQ |
Dec 12, 11:19
Utah Medical Products EPS Diluted (Quarterly): 0.8204 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -1.569 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Electromed, Inc. | 0.246 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.631M |
| Revenue (Quarterly) | 9.812M |
| Total Expenses (Quarterly) | 7.181M |
| Enterprise Value | 100.83M |
| Gross Profit Margin (Quarterly) | 51.56% |
| Profit Margin (Quarterly) | 26.81% |
| Earnings Yield | 6.08% |
| Operating Earnings Yield | 6.22% |
| Normalized Earnings Yield | 6.083 |